In the ever-evolving healthcare landscape, digital transformation is at the forefront, with telemedicine and artificial intelligence driving unprecedented innovation. These breakthroughs are not just reshaping healthcare delivery but also making it more accessible worldwide. As these pioneering advancements gain momentum, is global healthcare on the brink of transformative breakthroughs that will set new standards for accessibility and quality?
The next big kicker for healthcare business lies in single-speciality hospitals and specialty clinics, from nephrology to IVF, eye-care to dental care, dermatology and more. How does the growth opportunity look for different segments within healthcare?
Speakers:
Arpi Mehta, Founder, Toothsi
Amarinder Singh, Founder and CEO, Clove dental
Vikram Vuppala,Founder and CEO, Nephroplus
Sukesh Chandra, SVP & Head of Revenue and Operations, Birla fertility IVF
The Indian diagnostics sector has seen the larger players slowly taking market share from the neighbourhood shops. What is the next frontier for diagnostics firms? Are there newer pathology practice areas on the drawing board or inorganic expansion to go deeper the only way forward?
Speakers:
Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Ltd.
India's multispecialty hospital sector is witnessing a transformative phase, driven by increasing healthcare demand, a rising middle class, and growing insurance penetration. The integration of advanced medical technology, coupled with government initiatives like Ayushman Bharat, is broadening access to quality healthcare. The sector is also seeing a surge in private equity investments, spurring expansion into Tier-II and Tier-III cities.
Moreover, the focus on patient-centric care, telemedicine adoption, and strategic collaborations are reshaping the delivery model. As the population ages and lifestyle diseases surge, India's multispeciality hospitals are well-positioned to meet evolving healthcare needs, making this sector a cornerstone of the country's broader economic growth narrative.
Speakers:
Dilip Jose, MD & CEO, Manipal Health Enterprises Pvt Ltd
India has taken advantage of China+1 policy in tapping into the growing global demand for APIs. However, there is a scope for further improvement. What are the to-dos for Indian companies to make a bigger splash in the global API market?
Speakers:
Gunjan Singh, Head of Mature Markets, API, Dr. Reddy's
Prasanna Bora, MD - Lifesciences, o3 Capital
E-pharmacies have become an additional channel to reach to the patients. In a country where a medicine shop is around every nook and corner, how have e-pharmacies scaled up and how can they move up further in the value chain catering to the patient?
Speakers:
Ravishankar Gopalakrishnan, Whole-Time Director and Group COO, Medikabaazar
Prateek Verma, Head, Tata 1mg
India's regional multispeciality hospitals are emerging as global players by leveraging cutting-edge technology, specialized care, and cost-efficient healthcare delivery models. This panel discusses how these hospitals are scaling their expertise, adopting international best practices, and enhancing their global footprint through innovation, partnerships, and strategic investments.
Speakers:
Gautam Khanna, CEO, Hinduja hospital
Abhishek kapoor, CEO, Regency Health
Raajiv Singhal, Founding member, MD and Group CEO, Marengo Asia Hospitals
Abrarali Dalal, Managing Director and CEO, Sahyadri Hospitals
Ratan Jalan, Founder & Managing Director, Medium Healthcare Consulting
The "Platform Play" strategy, popular in Western markets, is gaining momentum among private equity firms looking to strengthen their footprint in India. Healthcare sector has been a hotbed of such strategy by PE investors, looking at a buy and build strategy.
However, this strategy is far from easy. It requires careful selection of the right platform company—one with a strong market position, scalable operations, and alignment with potential acquisitions. What factors should PE firms consider when choosing a platform company? How can they navigate the hurdles of executing a successful platform play?
Speakers:
Vishal Bali, Executive Chairman, Asia Healthcare Holdings
Swati Mehta, Director - Healthcare, o3 Capital
As artificial intelligence reshapes industries, the diagnostics sector is witnessing transformative advancements. From enhancing imaging precision to enabling predictive analytics, AI-driven innovations are revolutionizing disease detection, risk assessment, and personalized treatment strategies. This panel will explore how AI is breaking traditional barriers, addressing challenges like data integration and accuracy, and accelerating diagnostic processes. Experts will discuss the role of machine learning, the ethical implications of AI in diagnostics, and its potential to democratize healthcare access globally, offering a glimpse into the future of precision medicine.
The idea of India as a retirement migration destination is gaining traction. With its diverse landscape and affordable living and healthcare options, the country has the potential to attract retirees globally. That apart, the ageing population domestically also creates a captive market for senior living projects. This surge in demand for eldercare has already prompted investor interest in India’s senior living segment, with ventures in geriatric care securing funding from institutional backers. However, the industry faces challenges such as affordability constraints and societal acceptance, which could slow its momentum. How can the sector innovate to ensure accessibility while scaling effectively?
Speakers:
Adarsh Narahari, Managing Director, Primus Senior Living
Rajgopal G, Director & Group CEO, KITES Senior Care & Columbia Pacific Communities
Dr.Karthik Narayan R, Founder & MD, Athulya Senior Care
India’s anti-obesity market is poised for significant expansion, driven by increasing obesity rates and a scarcity of approved treatment options. Currently dominated by the off-label use of diabetes drugs, the market is on the verge of transformation with the anticipated entry of new therapies like Wegovy and Zepbound, alongside domestic biosimilars. These developments are expected to drive intense competition as companies vie to address the weight-loss needs of the world’s third most obese nation—a market projected to surge to $150 billion within the next decade.
How can international and domestic players address the unique challenges of a price-sensitive yet high-demand Indian market? Are Indian drugmakers prepared to compete with global firms in delivering affordable weight-loss solutions?
Speakers:
Dr Amit Kakar, Managing Partner & Head of Asia, Novo Holdings Asia
Kshitij Vijayvargiya, Managing Director and Partner at Boston Consulting Group (BCG), Healthcare and Digital Transformations
VCC Events opens up the avenues for participation. Join hands to be a part of India's largest gathering of alternative investments leaders, industry stakeholders and Asia’s influential limited partners, general partners and marquee advisors. Your chance to actively participate and augment yourself as thought leaders.
Dilip Jose is the Managing Director and CEO of Manipal Health Enterprises Pvt. Limited (Manipal Hospitals), an integrated healthcare services system and one of the largest hospitals network in India, with 37 facilities across 19 cities and over 10,500 beds.
He has more than 33 years of experience in various sectors and across functional areas. In healthcare, where he has spent the last 19 years, his previous assignment was as Group CEO of CARE Hospitals, managing a network of tertiary care facilities. Prior to that, he was the Regional Director with Fortis Healthcare, heading their operations in South India. Preceding that, he held leadership positions in the areas of Medical and Para-Medical education as well as tertiary healthcare delivery.
Before his move to the Healthcare sector, Mr Jose spent about 12 years in various roles in Corporate Finance and Strategy.
Raj is the Co-Founder & CEO of KITES Senior Care, a single specialty brand in geriatric care founded in Bangalore, South India in 2016. KITES Senior Care operates geriatric care centers and provides geriatric care at home & at senior living facilities. With 150+ beds under its management in three centers in Bengaluru & Hyderabad, KITES Senior Care has cared for over 4,500 elders since its inception both at their care facilities and at the residence of the elderly.
Raj commenced his healthcare journey as the CEO of Motherhood, a specialty in maternity care. He orchestrated a successful PE fund raise & a strategic acquisition which helped scale the brand from a single unit operations to multi-city multi-unit operations and its foray into treatment of infertility.
Prior to his entrepreneurial journey, he also served as the Chief Executive of HCG Milann, leader in the space of reproductive medicine offering infertility treatment solutions & related research initiatives where he worked closely with the Board in formulating the growth strategies of the company and was responsible for its successful execution.
In the past, he has had the privilege of having worked with an eclectic mix of successful organisations Eastern Spices, AOL Time Warner, Cairn Energy India & HPCL where he had the opportunity to learn and contribute meaningfully at various levels.
His success stories include building/scaling brands, taking companies through Strategic M&A deals/PE fund raising, setting up of businesses (start-up/bootstrap) including scaling them. He strongly believes in effective teams to deliver organizational goals and hence strives to invest, build and grow high performing teams. Raj's strengths as a leader are in (a) Customer centric approach (b) People/Process/Value based Governance and (c) Sound Strategy with Execution.
Raj is a Fellow member of the Institute of Chartered Accountants of India, New Delhi, an alumnus of ISB, Hyderabad (AMP) and holds a bachelor’s degree in Mathematics from Madras University. He also serves on the boards' of a super specialty hospital and a healthcare focused strategic advisory firm. He is extremely passionate about mentoring start-ups & sharing knowledge with budding entrepreneurs.
Adarsh Narahari is the Managing Director of Primus Senior Living, pioneering luxury communities for seniors in India. His entrepreneurial spirit and passion led to the creation of Primus, a brand dedicated to providing affluent, independent seniors with the best living options.
To ensure Primus offers unparalleled senior living experiences, Adarsh travelled extensively, studying the finest global retirement communities. His efforts have earned numerous accolades, including the ET Business Excellence Award for “Excellence in Creating Senior Living Communities” (2020), Times Business Awards for “Best Senior Living Community in Bangalore” (2021) and “Best Senior Citizen Community” (2022).
Under Adarsh’s leadership, Primus has set a new standard for senior living excellence. With over 3,500 senior homes being developed across six South Indian metros, Adarsh aims to promote healthy lifestyles and holistic care for seniors nationwide. His dedication earned him the “Young Entrepreneur of the Year” award in 2018 and 2023 by ET. In 2024 Adarsh got two of the most sought-after investors, General Catalyst and Nikhil Kamat to invest in Primus
Beyond Primus, Adarsh is the managing partner of ReWild Retreats , offering uber-luxurious, nature-based weekend getaways in stunning locations.
Adarsh holds a Master’s degree in Construction Management from the University of Leeds, UK, and a degree in Industrial Engineering and Management from RV College of Engineering, Bangalore. He has served, on the board of Entrepreneurs Organization, Bengaluru, and as the past chairman for ASLI (Association of Senior Living India).
A serial entrepreneur and seasoned executive with over twenty years of senior management and entrepreneurial experience in healthcare and software industries. Has worked in a spectrum of business environments from early stage companies (Clove, Simplexis, Amitive) to mid sized companies (i2, Bain&Co) and large companies (SAP, P&G).
Currently, is the founder and CEO of India's fastest growing chain of high-quality dental clinics. Healthcare in India lags behind WHO world averages and need for deploying good quality infrastructure is critical. Clove began operations in mid 2011 and as of November 2024 had over 550 dental centers offering all aspects of dental care to Indian consumers. Company is adding 90-120 centers every year as the infrastructure deployment tries to catch up to the need that exceeds 2500 new clinics every year (across India).
Also recognized leader in the cloud computing space having built one of the industry's leading and patented software application development platform (Amitive). In late 2010, GXS acquired Amitive's platform and migrated its entire application portfolio onto Amitive's platform.
A change agent with proven experience building products and companies both inside a large company and outside. At SAP, he lead and built SAP's RFID business into one of its fastest growing business units. In addition as SVP of Supply Chain, Product Lifecyle Mgmt. and Manufacturing solutions, managed a team of over 500 professionals and lead one of SAP's product areas globally and helped grow the business. At Simplexis he built a leading public sector procurement technology company. A company he started with some Harvard Business School colleagues and Senator Lamar Alexander who remained chairman of the company until company was sold in 2002.
He enjoys traveling, golf, tennis and spending time with family. He can be reached directly at amar@amarsingh.org
Dr. Raajiv Singhal is a distinguished healthcare professional and visionary leader with career spanning over 3 decades. His career combines clinical practice, operations & management, fundraising, and entrepreneurship. A graduate and post-graduate (MS, General Surgery) of the esteemed Armed Forces Medical College (AFMC) in Pune, Dr. Raajiv began his healthcare journey with the Indian Army. He dedicated his service to the nation in some of the most formidable environments, including the Siachen Glacier—the highest battlefield in the world, tough terrains of Northeast. He often walked as far as 40 kms through the dense jungles of the Northeast, delivering essential medical services to soldiers safeguarding our country.
His service in the Armed Forces was transformative; after operating on soldiers who sustained injuries and witnessing their recovery, he always felt a profound sense of fulfilment that stayed with him long after his military tenure. In his words, looking at the soldiers walking back to their loved ones after recovering from causalities sustained by gunshots, grenade splinter and mine blasts, provided the greatest degree of satisfaction and fulfilment to him ever. This experience inspired him to establish a healthcare brand on the principles of ‘Patient First’. Thus, Marengo Asia Hospitals was established on 21st October 2020, reflecting his commitment to quality care and healing The word Marengo stands for perseverance, the strength to face challenges, and the focus on bringing patients back home safely. It reflects dedication, resilience, and a commitment to providing the best care for everyone.
Transitioning from the armed forces to the corporate sector, Dr. Raajiv has emerged as a dynamic and thought leader in healthcare. As the Founding Member, Managing Director, and Group CEO of Marengo Asia Hospitals, he is recognized for his strategic acumen and innovative approach to transforming healthcare through a blend of technology and empathy. His concept of “Clinical Corridors” in the MVT space, based on the principles of 3Ts (Teach, Train, and Treat), is paving the way for capacity building across Asia and Africa. Additionally, he is the Co-Chair for Medical Value Travel (MVT) at FICCI and for Northern Region Healthcare at NatHealth.
Before embarking on his entrepreneurial journey in the year 2020, Dr. Raajiv was a key leader within the Evercare platform, which included 25 hospitals, 20 clinics, and a diagnostic chain across Asia and Africa. His expertise extended to private equity and strategic investment, where he led due diligence, asset localization, and strategic planning in diverse regions, including Ethiopia, Tanzania, Egypt, and South Africa. He also played a vital role in investor relations and capital raising team (Raised 1 Billion Dollar), contributing to the growth and positioning of healthcare entities for public listing. As Group CEO, he successfully navigated financial challenges, overseeing over 2,200 beds across 12 hospitals, making it one of the most notable success stories in Indian healthcare transformation.
Prior to this, he served as Regional Director of Fortis Escorts Heart Institute, where he was a pioneer in telemedicine and collaborative healthcare models. He established India's first e-ICU concept and developed Hub and Spoke models for Heart Command Centres across India and internationally, including in the UAE, Nepal, Tanzania and Bangladesh. His innovative contributions earned him the “Innovation in Healthcare Award” from the Government of Karnataka and the “Healthcare Leader of the Year Award”.
Dr. Raajiv's strategic insights are further demonstrated through various board roles, including Independent Director in Dhaka and Board Member positions in Durban and CARE hospitals, India. Driven by a passion for improving healthcare access and quality, he continues to drive a significant impact on the industry.
Vikram Vuppala is Founder & CEO of India’s largest dialysis network - NephroPlus. After spending 10 years in the US healthcare industry, his passion to redefine healthcare delivery in India prompted him to found NephroPlus in 2010. He has expanded NephroPlus to Asia’s leading dialysis network of 385+ centers in 230 cities across 4 Countries. NephroPlus has rapidly grown under Vikram’s leadership to become 6th largest dialysis network in the world. He had raised more than $100 MM in 5 rounds of Private equity funding over last 10 years from Bessemer Venture Partners (BVP), IFC (World Bank VC arm), Investcorp and IIFL.
Vikram’s vision of enabling people on dialysis worldwide lead long, happy and productive lives has enabled NephroPlus to redefine dialysis care across 4 countries and has positioned itself well to disrupt several other regions across the World in the near future.
Prior to founding NephroPlus, Vikram was a strategy consultant at McKinsey in the US. Vikram with over two and half decades of global healthcare experience has helped various healthcare firms on strategic issues such as business development, growth strategy, portfolio rationalization, and M&A. Prior to McKinsey, he worked at Abbott Healthcare and ZS Associates.
He has been a speaker at numerous international entrepreneurial, healthcare and investment conferences. Vikram did his B.Tech. from IIT-Kharagpur, M.S. from The University of Illinois, Chicago and an MBA from Chicago Booth.
He was the Group CEO for Fortis Healthcare Limited. Mr Bali was also the CEO and MD of Wockhardt Hospitals, where he spearheaded its development from a single branch to one of the largest specialty hospital chains. He also led its merger with Fortis Healthcare. As a board member of leading healthcare organizations, he has been a part of the Strategic Initiatives Group of Joint Commission International, US, and the Global Agenda Healthcare Council of the World Economic Forum. His keenness in globalization of healthcare has also led to case studies at the Harvard Business School.
Mr Abrarali Dalal is a healthcare industry veteran with an established track record. He was pivotal in building North India’s first private children hospital in his previous role as Group COO, Rainbow Children’s Hospitals. Earlier, he was Facility Director at Fortis Healthcare, New Delhi. He joined Sahyadri Hospitals as COO in December 2019, promoted as CEO in April 2021 and now is the Managing Director. The promotion was a result of navigating the group through huge challenges posted by the pandemic. Under his guidance, the Hospitals have gone digital and have also been effectively leveraging the power and reach of virtual platforms to organize ‘online clinics’ which has been a boon to many especially during the pandemic. Under his leadership, the Sahyadri group of Hospitals, which initially had 8 units, has now grown to 11. With his extensive and varied experience in healthcare operations, he successfully navigated the challenges of the COVID-19 period, collaborating closely with the local administration. Mr. Dalal completed his post-graduation in management from Pune University and has experience of 20 + years in Sales & Marketing and Operations & Administration.
Shiraz is a founding partner at o3 capital and has over 2 decades of extensive deal-making experience with a strong focus on the Healthcare and Lifesciences sectors. He has executed several deals worth billions of dollars and is one of the leading Investment Bankers in India.
He has been a keen observer and participant in the multi-fold expansion of India's Healthcare Landscape and has seen the industry grow and evolve to be a key driving force of the economy.
Before co-founding o3 Capital, Shiraz worked at Avendus Capital, where he was instrumental in setting up and leading their Healthcare and Lifesciences practice.
Shiraz holds an MBA degree from Melbourne Business School and is a B.E. Chemical graduate from Mumbai University.
Prasanna heads the Lifesciences practice at o3 Capital. He has over 17 years of experience in investment banking and has closed multiple transactions across sectors with a special focus on Healthcare and Pharma. He has product expertise in Private Equity Syndication, M&A and Structured Credit.
Prior to o3 Capital, he has worked with HDFC Bank in their investment banking division.
Prasanna holds an MBA degree from IIM Kozhikode and completed his graduation from Mumbai University.
Swati has over 15 years of deal-making experience across Private Equity, Mergers & Acquisitions and Equity Capital Markets. She has concluded transactions aggregating to $1.6 Billion in Healthcare and related verticals.
Prior to joining o3 Capital, Swati has worked in the Investment Banking division of UBS, Equirus Capital and IDFC.
She is a Chartered Financial Analyst, (CFA Institute, USA), holds an MBA degree from Symbiosis University and is a graduate from Shri Ram College of Commerce.
He completed his undergraduate from Simon Fraser University, Vancouver majoring in Finance and Human Resource. Post which Abhishek worked with PriceWater House Coopers, Ernst & Young, American Appraisal and Deloitte with the strategy consulting and merger and acquisition valuation practice. To hone his managerial skills, he went on to get his MBA from the prestigious Kellogg School of Management, Northwestern University, Chicago. Post his MBA he worked at Davita, the largest Kidney dialysis chain, in the United States, before returning to Kanpur to assist Regency in expanding and achieving its vision.
Ratan is widely regarded as a rare thought leader in the healthcare industry. It was a strong urge to make a difference in healthcare that led him to set up Medium Healthcare Consulting.
At Medium, Ratan plays a pivotal role in shaping Medium’s philosophy with particular thrust on innovation, execution and patient-centricity. He is personally involved in each engagement often setting up near-impossible internal benchmarks. His thought-provoking writings and talks on a wide variety of subjects continue to inspire many in the field.
Before founding Medium Healthcare, Ratan was the CEO of Apollo Health and Lifestyle Limited, part of the Apollo Hospitals Group, for almost a decade. He created some of the most successful and innovative healthcare formats in the country such as a nationwide network of The Apollo Clinic and The Cradle, South Asia’s first boutique birthing centres. He also led the strategic marketing initiatives and international projects for the group.
In 1996 Ratan, as President, set up India’s first hospital architecture and consulting firm Asian Health Services, a JV with ServiceMaster, then a Fortune 500 company. In a short span of three years, the firm became the undisputed leader in the field and had served leading organizations like Wockhardt
Hospitals, Escorts Hospital, Max Healthcare, Aditya Birla Foundation, BLK Hospitals, IL&FS and Gleneagles Hospitals.
He has over four decades of experience across diverse industries and functional responsibilities. He started his professional career in the information technology industry with HCL and then moved to advertising at Lintas (now MullenLowe Lintas Group). During his ten years there, he led work for major
Indian and international brands.
Dr. Karthik Narayan R is a distinguished healthcare leader with over 15 years of experience in geriatric care and hospital management. As the founder of Athulya Senior Care, he has revolutionized eldercare in India, combining clinical expertise with innovative management practices.
Dr. Amit Kakar joined Novo Holdings Asia in August 2020 as Head of Asia to lead investments and partnerships across the region, focusing primarily on the markets in China, Southeast Asia and India.
Dr. Kakar has more than 25 years of healthcare experience with several senior management roles across the globe and having worked in India, China, Singapore, Denmark and the USA.
His previous roles include Head of M&A and Business Development at Everlife Asia, Head of Healthcare Investments for Asia with the Avenue Capital Group, and various senior leadership positions with GE Healthcare.
Dr. Kakar is a Medical Doctor with a postgraduate degree in Radiation and Nuclear Medicine from Tata Memorial Hospital and Cancer Centre in Mumbai, India.
Mr. Gautam Khanna boasts a 33-year career in leadership roles within the business sector. Presently, he serves as the CEO of P.D. Hinduja Hospital & Medical Research Centre, achieving global recognition in Newsweek World's Best Hospital Rankings. Simultaneously, he leads Hinduja College of Nursing and participates in the governing council of K P B Hinduja College of Commerce. His previous tenure of 22 years at 3M, a multinational conglomerate, saw him as the Executive Director and Country Business Leader for 3M Healthcare Businesses in South Asia. He is actively engaged in numerous Indian industry associations, including QCI (Quality Council of India), AOH (Association of Hospitals) Mumbai, Nathealth, and FICCI. With multiple accolades and affiliations, Mr. Khanna is an alumnus of IIT Kanpur and IIM Calcutta.
Kshitij is a Managing Director and Partner in BCG's New Delhi office (India). Kshitij is part of BCG's Healthcare practice in India; and has ~14 years of experience in advising biopharma and healthcare companies across topics ranging from Strategy (business growth, portfolio, market entry, M&A), Sales and Marketing (brand launch, sales excellence, customer engagement) and Operations (Manufacturing, Procurement and Supply chain). He has also supported his clients on organization restructuring and culture transformations; and in embarking on digital enablement and transformations?
Prior to joining BCG, Kshitij has also set up a business unit for a tech enabled logistics company and grew it to a US$50M revenue within 2 years?
Some of Kshitij's recent experiences includes:?
India growth strategy for a global MNC pharmaco to grow 5-7X over 10 years through interventions across portfolio, customer segments, access to different coverage pools, market shaping and through initiatives on local partnerships and 'Make in India'?
Kshitij holds an MBA from the Indian Institute of Management, Calcutta and is a mechanical engineer?
Gunjan Singh currently heads the Mature Markets (US, Europe, Canada, Mexico, CIS) Sales for Dr. Reddy’s. He also heads the Strategy and Product Management functions. Previously, he was the CEO at Wanbury Ltd., and prior to that, he headed the API Business at Jubilant Pharma and headed Sales and Marketing at Piramal Pharma Solutions. Before his foray into pharma, Gunjan worked as a strategy consultant with Accenture Consulting. He has managed portfolio, strategy, BD, sales and P&L in various capacities and has worked across APIs, formulations and CDMO.
Dr. Kunal Sehgal is a Hematopathologist and Flow Cytometrist and currently is Managing Director and Chief Pathologist, Neuberg Sehgal Pathlab. He received his M.D. in Pathology from PGIMER Chandigarh and was awarded the gold medal for the best student of the university during his course. He worked as a fellow and senior resident in the Hematopathology laboratory at Tata Memorial Hospital (TMH), Mumbai. He has been awarded the UICC ICRETT AUF Fellowship during which he worked at the flowcytometry laboratories at John Hopkins University, Baltimore and at Seattle Cancer Care Alliance, Seattle –USA. He also worked as a Consultant in the Hematology Laboratory at PD Hinduja National Hospital, Mumbai from 2011-2015.
His main areas of interest are in the field of flow cytometry and newer parameters on CBC instruments. He has been actively involved in the development and standardization of six & eight color immunophenotyping at Hinduja Hospital and Tata Memorial Hospital. He has actively participated in various flowcytometry associated projects and training courses held at Hinduja and TMH and as part of the The Cytometry Society-India and INDO US conferences. He has presented papers at both national and international conferences. He is a certified NABL auditor for hematology and clinical pathology. He is a life member and Joint secretary of The Cytometry Society of India, and member of Mumbai Hematology Group and Indian Society of Hematology and Transfusion Medicine.
Drop us a line and we will call you.
